Cardiovascular risk profile at the onset of psoriatic arthritis: A population-based cohort study

F. C. Ernste, M. Sánchez-Menéndez, K. M. Wilton, Cynthia Crowson, Eric Lawrence Matteson, Hilal D Maradit Kremers

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Objective The role of cardiovascular disease (CVD) risk factors in psoriatic arthritis (PsA) is poorly understood. We examined the prevalence of CVD risk factors at initial onset of PsA and compared the observed incidence of CVD events with that predicted by the Framingham Risk Score (FRS) to determine its applicability in this patient population. Methods A population-based incidence cohort of 158 patients with PsA who fulfilled Classification of Psoriatic Arthritis criteria for PsA in 1989-2008 was assembled. Medical records were reviewed to ascertain CVD risk factors and CVD events. Future risk of CVD was estimated using the FRS algorithm. Results Mean age was 43.4 years (range 19-74 years), 61% were men, and 44% were obese (body mass index ≥30 kg/m<sup>2</sup>). Fifty-four patients (34%) presented with ≥2 CVD risk factors at PsA incidence. Among 126 patients ages ≥30 years at PsA incidence with no prior history of CVD, 33% had an FRS ≥10%, with 11% having an FRS ≥20%, and 18 experienced a CVD event in the first 10 years of disease duration. The 10-year cumulative incidence of CVD events was 17% (95% confidence interval [95% CI] 10%-24%), almost twice as high as the predicted incidence based on the FRS (standardized incidence ratio 1.80, 95% CI 1.14-2.86; P-=-0.012). Conclusion The majority of newly diagnosed PsA patients have a >10% risk of CVD within 10 years of PsA incidence. The CVD risk in these patients is higher than expected and underestimated by the FRS.

Original languageEnglish (US)
Pages (from-to)1015-1021
Number of pages7
JournalArthritis Care and Research
Volume67
Issue number7
DOIs
StatePublished - Jul 1 2015

Fingerprint

Psoriatic Arthritis
Cohort Studies
Cardiovascular Diseases
Population
Incidence
Confidence Intervals
Medical Records
Body Mass Index

ASJC Scopus subject areas

  • Rheumatology

Cite this

Cardiovascular risk profile at the onset of psoriatic arthritis : A population-based cohort study. / Ernste, F. C.; Sánchez-Menéndez, M.; Wilton, K. M.; Crowson, Cynthia; Matteson, Eric Lawrence; Maradit Kremers, Hilal D.

In: Arthritis Care and Research, Vol. 67, No. 7, 01.07.2015, p. 1015-1021.

Research output: Contribution to journalArticle

@article{025fe39334c94afbbaf9b57979d1e744,
title = "Cardiovascular risk profile at the onset of psoriatic arthritis: A population-based cohort study",
abstract = "Objective The role of cardiovascular disease (CVD) risk factors in psoriatic arthritis (PsA) is poorly understood. We examined the prevalence of CVD risk factors at initial onset of PsA and compared the observed incidence of CVD events with that predicted by the Framingham Risk Score (FRS) to determine its applicability in this patient population. Methods A population-based incidence cohort of 158 patients with PsA who fulfilled Classification of Psoriatic Arthritis criteria for PsA in 1989-2008 was assembled. Medical records were reviewed to ascertain CVD risk factors and CVD events. Future risk of CVD was estimated using the FRS algorithm. Results Mean age was 43.4 years (range 19-74 years), 61{\%} were men, and 44{\%} were obese (body mass index ≥30 kg/m2). Fifty-four patients (34{\%}) presented with ≥2 CVD risk factors at PsA incidence. Among 126 patients ages ≥30 years at PsA incidence with no prior history of CVD, 33{\%} had an FRS ≥10{\%}, with 11{\%} having an FRS ≥20{\%}, and 18 experienced a CVD event in the first 10 years of disease duration. The 10-year cumulative incidence of CVD events was 17{\%} (95{\%} confidence interval [95{\%} CI] 10{\%}-24{\%}), almost twice as high as the predicted incidence based on the FRS (standardized incidence ratio 1.80, 95{\%} CI 1.14-2.86; P-=-0.012). Conclusion The majority of newly diagnosed PsA patients have a >10{\%} risk of CVD within 10 years of PsA incidence. The CVD risk in these patients is higher than expected and underestimated by the FRS.",
author = "Ernste, {F. C.} and M. S{\'a}nchez-Men{\'e}ndez and Wilton, {K. M.} and Cynthia Crowson and Matteson, {Eric Lawrence} and {Maradit Kremers}, {Hilal D}",
year = "2015",
month = "7",
day = "1",
doi = "10.1002/acr.22536",
language = "English (US)",
volume = "67",
pages = "1015--1021",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - Cardiovascular risk profile at the onset of psoriatic arthritis

T2 - A population-based cohort study

AU - Ernste, F. C.

AU - Sánchez-Menéndez, M.

AU - Wilton, K. M.

AU - Crowson, Cynthia

AU - Matteson, Eric Lawrence

AU - Maradit Kremers, Hilal D

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Objective The role of cardiovascular disease (CVD) risk factors in psoriatic arthritis (PsA) is poorly understood. We examined the prevalence of CVD risk factors at initial onset of PsA and compared the observed incidence of CVD events with that predicted by the Framingham Risk Score (FRS) to determine its applicability in this patient population. Methods A population-based incidence cohort of 158 patients with PsA who fulfilled Classification of Psoriatic Arthritis criteria for PsA in 1989-2008 was assembled. Medical records were reviewed to ascertain CVD risk factors and CVD events. Future risk of CVD was estimated using the FRS algorithm. Results Mean age was 43.4 years (range 19-74 years), 61% were men, and 44% were obese (body mass index ≥30 kg/m2). Fifty-four patients (34%) presented with ≥2 CVD risk factors at PsA incidence. Among 126 patients ages ≥30 years at PsA incidence with no prior history of CVD, 33% had an FRS ≥10%, with 11% having an FRS ≥20%, and 18 experienced a CVD event in the first 10 years of disease duration. The 10-year cumulative incidence of CVD events was 17% (95% confidence interval [95% CI] 10%-24%), almost twice as high as the predicted incidence based on the FRS (standardized incidence ratio 1.80, 95% CI 1.14-2.86; P-=-0.012). Conclusion The majority of newly diagnosed PsA patients have a >10% risk of CVD within 10 years of PsA incidence. The CVD risk in these patients is higher than expected and underestimated by the FRS.

AB - Objective The role of cardiovascular disease (CVD) risk factors in psoriatic arthritis (PsA) is poorly understood. We examined the prevalence of CVD risk factors at initial onset of PsA and compared the observed incidence of CVD events with that predicted by the Framingham Risk Score (FRS) to determine its applicability in this patient population. Methods A population-based incidence cohort of 158 patients with PsA who fulfilled Classification of Psoriatic Arthritis criteria for PsA in 1989-2008 was assembled. Medical records were reviewed to ascertain CVD risk factors and CVD events. Future risk of CVD was estimated using the FRS algorithm. Results Mean age was 43.4 years (range 19-74 years), 61% were men, and 44% were obese (body mass index ≥30 kg/m2). Fifty-four patients (34%) presented with ≥2 CVD risk factors at PsA incidence. Among 126 patients ages ≥30 years at PsA incidence with no prior history of CVD, 33% had an FRS ≥10%, with 11% having an FRS ≥20%, and 18 experienced a CVD event in the first 10 years of disease duration. The 10-year cumulative incidence of CVD events was 17% (95% confidence interval [95% CI] 10%-24%), almost twice as high as the predicted incidence based on the FRS (standardized incidence ratio 1.80, 95% CI 1.14-2.86; P-=-0.012). Conclusion The majority of newly diagnosed PsA patients have a >10% risk of CVD within 10 years of PsA incidence. The CVD risk in these patients is higher than expected and underestimated by the FRS.

UR - http://www.scopus.com/inward/record.url?scp=84932617838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932617838&partnerID=8YFLogxK

U2 - 10.1002/acr.22536

DO - 10.1002/acr.22536

M3 - Article

C2 - 25581120

AN - SCOPUS:84932617838

VL - 67

SP - 1015

EP - 1021

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 7

ER -